Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework

被引:418
|
作者
Alsaiari, Shahad K. [1 ]
Patil, Sachin [1 ]
Alyami, Mram [1 ]
Alamoudi, Kholod O. [1 ]
Aleisa, Fajr A. [2 ]
Merzaban, Jasmeen S. [2 ]
Li, Mo [3 ]
Khashab, Niveen M. [1 ]
机构
[1] King Abdullah Univ Sci & Technol KAUST, Adv Membranes & Porous Mat Ctr, Smart Hybrid Mat SHMs Lab, Thuwal 239556900, Saudi Arabia
[2] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Cell Migrat & Signaling Lab, Thuwal 239556900, Saudi Arabia
[3] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Stem Cell & Regenerat Lab, Thuwal 239556900, Saudi Arabia
关键词
METAL-ORGANIC FRAMEWORKS; IN-VIVO; RNA; CHALLENGES; SYSTEM; CELLS; VITRO; CAS9;
D O I
10.1021/jacs.7b11754
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
CRISPR/Cas9 is a combined protein (Cas9) and an engineered single guide RNA (sgRNA) genome editing platform that offers revolutionary solutions to genetic diseases. It has, however, a double delivery problem owning to the large protein size and the highly charged RNA component. In this work, we report the first example of CRISPR/Cas9 encapsulated by nanoscale zeolitic imidazole frameworks (ZIFs) with a loading efficiency of 17% and enhanced endosomal escape promoted by the protonated imidazole moieties. The gene editing potential of CRISPR/Cas9 encapsulated by ZIF-8 (CC-ZIFs) is further verified by knocking down the gene expression of green fluorescent protein by 37% over 4 days. The nanoscale CC-ZIFs are biocompatible and easily scaled-up offering excellent loading capacity and controlled codelivery of intact Cas9 protein and sgRNA.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [31] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [32] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [33] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [34] CRISPR/Cas9 editing of the genome for cancer modeling
    Guernet, Alexis
    Grumolato, Luca
    METHODS, 2017, 121 : 130 - 137
  • [35] Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing
    Zhang, Zhen
    Wan, Tao
    Chen, Yuxuan
    Chen, Yu
    Sun, Hongwei
    Cao, Tianqi
    Zhou Songyang
    Tang, Guping
    Wu, Chuanbin
    Ping, Yuan
    Xu, Fu-Jian
    Huang, Junjiu
    MACROMOLECULAR RAPID COMMUNICATIONS, 2019, 40 (05)
  • [36] Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
    Brittany E. Givens
    Youssef W. Naguib
    Sean M. Geary
    Eric J. Devor
    Aliasger K. Salem
    The AAPS Journal, 20
  • [37] Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
    Huan Deng
    Wei Huang
    Zhiping Zhang
    Nano Research, 2019, 12 : 2437 - 2450
  • [38] Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
    Deng, Huan
    Huang, Wei
    Zhang, Zhiping
    NANO RESEARCH, 2019, 12 (10) : 2437 - 2450
  • [39] Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
    Givens, Brittany E.
    Naguib, Youssef W.
    Geary, Sean M.
    Devor, Eric J.
    Salem, Aliasger K.
    AAPS JOURNAL, 2018, 20 (06):
  • [40] Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
    Gori, Jennifer L.
    Hsu, Patrick D.
    Maeder, Morgan L.
    Shen, Shen
    Welstead, G. Grant
    Bumcrot, David
    HUMAN GENE THERAPY, 2015, 26 (07) : 443 - 451